
Investornewsbreaks Nutriband Inc. (NASDAQ: NTRB) Declares 25% Preferred Stock Dividend Linked To AVERSA Fentanyl Approval
To view the full report, visit
About Nutriband Inc.
Nutriband is primarily engaged in the development of a portfolio of transdermal pharmaceutical products. Its lead product under development is an abuse-deterrent fentanyl patch incorporating its AVERSA(TM) abuse-deterrent technology. AVERSA technology can be incorporated into any transdermal patch to prevent the abuse, misuse, diversion, and accidental exposure of drugs with abuse potential. For more information about the company, visit .
NOTE TO INVESTORS: The latest news and updates relating to NTRB are available in the company's newsroom at
About InvestorWire
InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers : (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries ; (2) article and editorial syndication to 5,000+ outlets ; (3) enhanced press release enhancement to ensure maximum impact ; (4) social media distribution via IBN to millions of social media followers ; and (5) a full array of tailored corporate communications solutions . With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today's market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.
For more information, please visit
Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: /Disclaimer
InvestorWire
Austin, Texas
512.354.7000 Office
[email protected]
InvestorWire is powered by IBN
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research

- Biomatrix Surpasses 5 Million Verified Users, Setting New Standards For Real Human Engagement In Web3
- Moca Foundation Announces Moca Chain For Self-Sovereign, Privacy-Preserving Identity And User Verification
- Independence Benefits Helps Federal Employees Navigate Retirement Amid VSIP Offers, TSP Volatility, And FEGLI Cost Increases
- Primexbt Launches MT5 PRO Account With Superior Conditions For High-Volume Traders
- NEXST Launches Web3 VR Entertainment Platform With K-Pop Group UNIS As First Global Partner
- Galxe Starboard Leads Infofi Boom With 5 Million Engagements
Comments
No comment